Louise Nash

About
Representative Matters
Credentials

About
Louise Nash is a corporate partner based in Covington's London office.

Louise has over 25 years’ experience of global acquisitions and divestitures for multinational companies as well as complex commercial transactions including joint ventures and licensing transactions. Her practice is international, with virtually all transactions upon which she advises having a cross-border dimension, and she has led global restructuring transactions, including both pre-deal separation and post-merger integration projects in over 100 jurisdictions. As such, she has extensive experience of dealing with the challenges presented by complex cross-border projects. She has particular experience in the consumer goods, life sciences, and technology sectors.

Louise has been recognized by leading directories, including as a “Leading Individual M&A: Premium and Mid-Market Deals” by Legal 500 and as “Best in M&A” by LMG Euromoney on several occasions. Louise served an eight-year term on the firm’s Management Committee and currently chairs the firm’s Global Technology Industry group.
Areas of Expertise

Corporate

Finance

Capital Markets and Securities

Mergers and Acquisitions

Private Equity

Venture Capital and Emerging Companies

Integration and Legal Entity Structuring

Regulatory and Public Policy

Antitrust/Competition

Consumer Brands

Internet of Things

Artificial Intelligence

Technology

Connected and Autonomous Vehicles

Energy

Other Renewables
Practices and Industries
Representative Matters
- Advising Renesas Electronics Corporation on its €4.9 billion acquisition of Dialog Semiconductor plc.
- Advising Eaton in its $2.83 billion acquisition of Cobham Mission Systems (CMS).
- Representing Elanco in connection a series of antitrust-mandated divestitures in preparation for the $7.6 billion acquisition of Bayer Animal Health. These include an agreement with French pharmaceutical company Vetoquinol to divest the European Economic Area, UK, Canadian and Australian rights to the Drontal and Profender product families for US$150 million as well as an agreement with Merck Animal Health to divest the worldwide rights to Elanco's Vecoxan product for $55 million and divestiture of a number of development products.
- Merck in its:
  
  the global separation of its Organon business in preparation for the $6.5bn spin off of its women's health business;
  
  €2.1 billion acquisition of Antelliq Group, a leader in digital animal identification, traceability and monitoring solutions, the fastest growing part of the animal health industry; and
  
  multi-year global merger integration with Schering-Plough.
Qualcomm Inc. on various European acquisitions including:

its $2.5bn recommended cash offer for CSR plc;

the purchase of assets in a UK-based 450 MHz handset design and manufacturing company;

the acquisition of Elata Holdings Limited; and

the acquisition of Trigenix Limited.

Eli Lilly’s Elanco Animal Health division on a number of cross-border transactions including:

the sale of its Dundee animal vaccines plant to Argenta Ltd; and

the sale of its Posilac business and manufacturing plant in Augusta, Georgia, to Brazilian company Union Agener.

Giorgio Armani S.p.A. on numerous international transactions including:

the acquisition of its retail and wholesale business in the United Kingdom from long-term retail partner Club 21;

a collaboration with a listed Dubai property company for the development of a worldwide chain of Armani hotels and resorts;

a joint venture with an Indian property consortium for the import, sale and distribution of Armani branded goods in India; and

the re-purchase of a 50% equity stake in the A/X Armani Exchange brand and the related global licensing and retail arrangements.
Areas of Expertise

Corporate

Finance

Capital Markets and Securities

Mergers and Acquisitions

Private Equity

Venture Capital and Emerging Companies

Integration and Legal Entity Structuring

Regulatory and Public Policy

Antitrust/Competition

Consumer Brands

Internet of Things

Artificial Intelligence

Technology

Connected and Autonomous Vehicles

Energy

Other Renewables

Credentials

Education	College of Law, Guildford, J.D., 1993 University of Surrey, 1992 with honours
Bar Admissions	Solicitor of the Senior Courts of England and Wales
Languages	French German
Accolades	Euromoney Legal Media Group, Europe Women in Business Law Awards: Lawyer of the Yearfor Mergers & Acquisitions (2022; 2015-2017) MergerLinks Top Technology Lawyers in EMEA (2021) Expert Guides, Banking, Finance & Transactional, M&A and Women in Business Law (2021) WTR1000, Transactions (2015-2016) The Lawyer Hot 100 (2014) Chambers UK, Corporate/M&A: £100-800 million (2024) and Private Equity, Venture Capital Investment (2009-2022) Legal 500 UK, M&A: Upper Mid-Market and Premium Deals £500M+ (2021-2022) Legal 500 UK, M&A: Lower Mid-Market Deals £50M-£500M (2021) Legal 500 UK, Commercial Contracts (2015-2016) Legal 500 UK, Venture Capital (2021; 2008-2016) Legal 500 UK, Media and Entertainment (2008-2015) Legal 500 UK, Pharmaceuticals & Biotechnology (2009) IFLR European Awards 2015 - shortlisted in Deals of the Year: M&A

Professionals

Recently Viewed

Covington To Open Boston Office With Broad-Based Life Sciences Capabilities

Practices and Industries

Sustainability Toolkit: What GCs Need to Know

Recently Viewed

News You May Be Interested In

PR Contacts

David Schaefer

Maria Ivy

Global Reach

Global Problem Solving from Covington: Deal with Complex Problems Anywhere in the World

How Can We Help You?

Global Problem Solving from Covington: Deal with Complex Problems Anywhere in the World

Louise Nash

Areas of Expertise

Areas of Expertise

Areas of Expertise

News and Insights

Events